Systane Complete Emulsion
Pricing Report NDC 0065-0481-10

Current NADAC: $1.16753 per ML · Effective Sep 23, 2026 · Est. package price $11.68 (10 ML)

Current Package Pricing Information

The current wholesale acquisition cost for Systane Complete (NDC 0065-0481-10) is $1.16753 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human over the counter drug provided by Alcon Laboratories, Inc., this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.16753
Per ML

Effective Date
Sep 23, 2026
Billable Units
10 ML
Estimated Package Price
$11.68
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2018, the NADAC wholesale price for (NDC ) has moved within a range of $0.83010 to $1.36731 per ML. Over this 8 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8301 - $1.3584
Market Volatility
63.64% Variance
Latest Trend
0.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $1.16753 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Sep 23, 2026 $1.00173 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Sep 23, 2026 $1.36145 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 19, 2026 $1.16863 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 19, 2026 $1.00097 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 19, 2026 $1.36731 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $1.16887 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $0.98741 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jul 22, 2026 $1.36633 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $1.16679 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $0.98551 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 17, 2026 $1.35466 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026